Subcutaneous T-cell lymphoma (also known as a "panniculitis-like T-cell lymphoma") is a cutaneous condition that most commonly presents in young adults, and is characterized by subcutaneous nodules.
Common symptoms include fever, fatigue, and pancytopenia.
Diagnosis
Classification
Subcutaneous panniculitis-like T-cell lymphoma, is a subtype of
Peripheral T-cell lymphoma
Peripheral T-cell lymphoma refers to a group of T-cell lymphomas that develop away from the thymus or bone marrow.
Examples include:
* Cutaneous T-cell lymphomas
* Angioimmunoblastic T-cell lymphoma
* Extranodal natural killer/T-cell lymphoma, ...
. Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive
lymphomas that develop from mature-stage white blood cells called
T-cells
A T cell is a type of lymphocyte. T cells are one of the important white blood cells of the immune system and play a central role in the adaptive immune response. T cells can be distinguished from other lymphocytes by the presence of a T-cell re ...
and natural killer cells (
NK cells
Natural killer cells, also known as NK cells or large granular lymphocytes (LGL), are a type of cytotoxic lymphocyte critical to the innate immune system that belong to the rapidly expanding family of known innate lymphoid cells (ILC) and repres ...
) (see figure for an overview of PTCL subtypes). PTCL is a type of
non-Hodgkin’s lymphoma (NHL). NHL affects two particular types of white blood cells:
B-cells
B cells, also known as B lymphocytes, are a type of white blood cell of the lymphocyte subtype. They function in the humoral immunity component of the adaptive immune system. B cells produce antibody molecules which may be either secreted or ...
and T-cells. PTCL specifically affects T-cells, and results when T-cells develop and grow abnormally.
Subcutaneous Panniculitis-like T-cell Lymphoma is a rare type of lymphoma that infiltrates the subcutaneous fat but does not involve the skin. There are two subtypes – alpha-beta and gamma-delta. Patients with the gamma-delta subtype have a more aggressive clinical course.
It is described as
CD3+/
CD4-/
CD8+, with
CD30
CD30, also known as TNFRSF8 ( TNF receptor superfamily member 8), is a cell membrane protein of the tumor necrosis factor receptor family and a tumor marker.
Function
This receptor is expressed by activated, but not by resting, T and B cel ...
and
CD56 usually negative.
Treatment
Historically, Subcutaneous Panniculitis-like T-cell Lymphoma, as with other types of T-cell lymphoma, was treated similarly to B-cell lymphomas. However, in recent years, scientists have developed techniques to better recognize the different types of lymphomas, such as PTCL. It is now understood that PTCL behaves differently from B-cell lymphomas and therapies are being developed that specifically target these types of lymphoma. Currently, however, there are no drugs approved by the
U.S. Food and Drug Administration (FDA) specifically for PTCL. There are two drugs, Pralatrexate and Romidepsin, which are both approved by the FDA for relapsed or refractory T cell lymphoma.
Anthracycline
Anthracyclines are a class of drugs used in cancer chemotherapy that are extracted from ''Streptomyces'' bacterium. These compounds are used to treat many cancers, including leukemias, lymphomas, breast, stomach, uterine, ovarian, bladder ...
-containing
chemotherapy regimens are commonly offered as the initial therapy. Some patients may receive an autologous or allogeneic
stem cell transplant
Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood in order to replicate inside of a patient and to produce ...
. Novel approaches to the treatment of PTCL in the relapsed or refractory setting are under investigation.
CHOP or CHOP-like regimens have been used.
Research
Pralatrexate is one compound currently under investigation to add to the frontline treatment of PTCL. It is currently approved by the FDA for relapsed or refractory T cell lymphoma. Side effects include mouth sores, which can be severe.
See also
*
Cutaneous T-cell lymphoma
Cutaneous T-cell lymphoma (CTCL) is a class of non-Hodgkin lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin lymphomas (which are generally B-cell-related), CTCL is caused by a mutation of T cells. The cancer ...
*
Lennert lymphoma
*
Skin lesion
A skin condition, also known as cutaneous condition, is any medical condition that affects the integumentary system—the organ system that encloses the body and includes skin, nails, and related muscle and glands. The major function of thi ...
References
External links
{{Medical resources
, ICD10 = C83.6
, ICD9 =
, ICDO =
, OMIM =
, DiseasesDB =
, MedlinePlus =
, eMedicineSubj =
, eMedicineTopic =
, MeSH = C537503
, GeneReviewsNBK =
, GeneReviewsName =
, Orphanet = 86884
Lymphoid-related cutaneous conditions